Advanced search options

Advanced Search Options 🞨

Browse by author name (“Author name starts with…”).

Find ETDs with:

in
/  
in
/  
in
/  
in

Written in Published in Earliest date Latest date

Sorted by

Results per page:

Sorted by: relevance · author · university · dateNew search

You searched for +publisher:"University of North Carolina" +contributor:("McLeod, Howard L."). Showing records 1 – 8 of 8 total matches.

Search Limiters

Last 2 Years | English Only

No search limiters apply to these results.

▼ Search Limiters


University of North Carolina

1. Watson, Roshawn. Molecular profiling of clinical drug resistance.

Degree: 2010, University of North Carolina

 One of the greatest challenges in oncology is drug resistance. 5-Fluorouracil (5- FU) is the third most commonly used anti-neoplastic, so lack of initial or… (more)

Subjects/Keywords: Eshelman School of Pharmacy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Watson, R. (2010). Molecular profiling of clinical drug resistance. (Thesis). University of North Carolina. Retrieved from https://cdr.lib.unc.edu/record/uuid:a469fb24-63fb-4f05-8b17-142b9d90f6c8

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Watson, Roshawn. “Molecular profiling of clinical drug resistance.” 2010. Thesis, University of North Carolina. Accessed September 19, 2020. https://cdr.lib.unc.edu/record/uuid:a469fb24-63fb-4f05-8b17-142b9d90f6c8.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Watson, Roshawn. “Molecular profiling of clinical drug resistance.” 2010. Web. 19 Sep 2020.

Vancouver:

Watson R. Molecular profiling of clinical drug resistance. [Internet] [Thesis]. University of North Carolina; 2010. [cited 2020 Sep 19]. Available from: https://cdr.lib.unc.edu/record/uuid:a469fb24-63fb-4f05-8b17-142b9d90f6c8.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Watson R. Molecular profiling of clinical drug resistance. [Thesis]. University of North Carolina; 2010. Available from: https://cdr.lib.unc.edu/record/uuid:a469fb24-63fb-4f05-8b17-142b9d90f6c8

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of North Carolina

2. Watson, Venita Gresham. An ex vivo Familial Genetic Strategy for Determining Mechanism of Action.

Degree: 2010, University of North Carolina

 One of the greatest challenges in anticancer drug development is the discovery of molecular targets and biochemical interactions required for drug action. Lapses in drug… (more)

Subjects/Keywords: Eshelman School of Pharmacy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Watson, V. G. (2010). An ex vivo Familial Genetic Strategy for Determining Mechanism of Action. (Thesis). University of North Carolina. Retrieved from https://cdr.lib.unc.edu/record/uuid:ec757221-6a3c-48f7-9dec-491ebd40f9e0

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Watson, Venita Gresham. “An ex vivo Familial Genetic Strategy for Determining Mechanism of Action.” 2010. Thesis, University of North Carolina. Accessed September 19, 2020. https://cdr.lib.unc.edu/record/uuid:ec757221-6a3c-48f7-9dec-491ebd40f9e0.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Watson, Venita Gresham. “An ex vivo Familial Genetic Strategy for Determining Mechanism of Action.” 2010. Web. 19 Sep 2020.

Vancouver:

Watson VG. An ex vivo Familial Genetic Strategy for Determining Mechanism of Action. [Internet] [Thesis]. University of North Carolina; 2010. [cited 2020 Sep 19]. Available from: https://cdr.lib.unc.edu/record/uuid:ec757221-6a3c-48f7-9dec-491ebd40f9e0.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Watson VG. An ex vivo Familial Genetic Strategy for Determining Mechanism of Action. [Thesis]. University of North Carolina; 2010. Available from: https://cdr.lib.unc.edu/record/uuid:ec757221-6a3c-48f7-9dec-491ebd40f9e0

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of North Carolina

3. Hertz, Daniel L. Pharmacogenetic Predictors of Taxane-Induced Peripheral Neuropathy.

Degree: 2013, University of North Carolina

 Peripheral neuropathy is an adverse event of taxane treatment that is related both to the patient's cumulative drug exposure and their inherent sensitivity to neurotoxicity.… (more)

Subjects/Keywords: Eshelman School of Pharmacy; Division of Pharmacotherapy and Experimental Therapeutics

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Hertz, D. L. (2013). Pharmacogenetic Predictors of Taxane-Induced Peripheral Neuropathy. (Thesis). University of North Carolina. Retrieved from https://cdr.lib.unc.edu/record/uuid:87a8e880-afca-448e-b2c2-9b7b00bf0655

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Hertz, Daniel L. “Pharmacogenetic Predictors of Taxane-Induced Peripheral Neuropathy.” 2013. Thesis, University of North Carolina. Accessed September 19, 2020. https://cdr.lib.unc.edu/record/uuid:87a8e880-afca-448e-b2c2-9b7b00bf0655.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Hertz, Daniel L. “Pharmacogenetic Predictors of Taxane-Induced Peripheral Neuropathy.” 2013. Web. 19 Sep 2020.

Vancouver:

Hertz DL. Pharmacogenetic Predictors of Taxane-Induced Peripheral Neuropathy. [Internet] [Thesis]. University of North Carolina; 2013. [cited 2020 Sep 19]. Available from: https://cdr.lib.unc.edu/record/uuid:87a8e880-afca-448e-b2c2-9b7b00bf0655.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Hertz DL. Pharmacogenetic Predictors of Taxane-Induced Peripheral Neuropathy. [Thesis]. University of North Carolina; 2013. Available from: https://cdr.lib.unc.edu/record/uuid:87a8e880-afca-448e-b2c2-9b7b00bf0655

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of North Carolina

4. Maxfield, Kimberly. Genetic Dissection of Therapeutic Intervention Targets in Triple Negative Breast Cancer.

Degree: Pharmacology, 2015, University of North Carolina

 Triple negative breast cancer (TNBC) is the most aggressive and metastatic type of breast cancer, accounting for 20% of all breast cancer diagnoses. Currently, there… (more)

Subjects/Keywords: Pharmacology; Biology; School of Medicine; Department of Pharmacology

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Maxfield, K. (2015). Genetic Dissection of Therapeutic Intervention Targets in Triple Negative Breast Cancer. (Thesis). University of North Carolina. Retrieved from https://cdr.lib.unc.edu/record/uuid:318b1399-81a7-4737-b0c7-96f242284420

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Maxfield, Kimberly. “Genetic Dissection of Therapeutic Intervention Targets in Triple Negative Breast Cancer.” 2015. Thesis, University of North Carolina. Accessed September 19, 2020. https://cdr.lib.unc.edu/record/uuid:318b1399-81a7-4737-b0c7-96f242284420.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Maxfield, Kimberly. “Genetic Dissection of Therapeutic Intervention Targets in Triple Negative Breast Cancer.” 2015. Web. 19 Sep 2020.

Vancouver:

Maxfield K. Genetic Dissection of Therapeutic Intervention Targets in Triple Negative Breast Cancer. [Internet] [Thesis]. University of North Carolina; 2015. [cited 2020 Sep 19]. Available from: https://cdr.lib.unc.edu/record/uuid:318b1399-81a7-4737-b0c7-96f242284420.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Maxfield K. Genetic Dissection of Therapeutic Intervention Targets in Triple Negative Breast Cancer. [Thesis]. University of North Carolina; 2015. Available from: https://cdr.lib.unc.edu/record/uuid:318b1399-81a7-4737-b0c7-96f242284420

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of North Carolina

5. Gillis, Nancy. Exploring Clinical and Genetic Factors to Optimize the Use of Tyrosine Kinase Inhibitors in Clinical Practice.

Degree: 2017, University of North Carolina

 Multi-targeted tyrosine kinase inhibitors (TKIs) are widely prescribed anticancer agents that provide significant benefit in survival across a range of cancers; however, 20-30% of individuals… (more)

Subjects/Keywords: Eshelman School of Pharmacy; Division of Pharmacotherapy and Experimental Therapeutics

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Gillis, N. (2017). Exploring Clinical and Genetic Factors to Optimize the Use of Tyrosine Kinase Inhibitors in Clinical Practice. (Thesis). University of North Carolina. Retrieved from https://cdr.lib.unc.edu/record/uuid:daa2bfd7-dbd7-45bc-a81f-03e520f2abea

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Gillis, Nancy. “Exploring Clinical and Genetic Factors to Optimize the Use of Tyrosine Kinase Inhibitors in Clinical Practice.” 2017. Thesis, University of North Carolina. Accessed September 19, 2020. https://cdr.lib.unc.edu/record/uuid:daa2bfd7-dbd7-45bc-a81f-03e520f2abea.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Gillis, Nancy. “Exploring Clinical and Genetic Factors to Optimize the Use of Tyrosine Kinase Inhibitors in Clinical Practice.” 2017. Web. 19 Sep 2020.

Vancouver:

Gillis N. Exploring Clinical and Genetic Factors to Optimize the Use of Tyrosine Kinase Inhibitors in Clinical Practice. [Internet] [Thesis]. University of North Carolina; 2017. [cited 2020 Sep 19]. Available from: https://cdr.lib.unc.edu/record/uuid:daa2bfd7-dbd7-45bc-a81f-03e520f2abea.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Gillis N. Exploring Clinical and Genetic Factors to Optimize the Use of Tyrosine Kinase Inhibitors in Clinical Practice. [Thesis]. University of North Carolina; 2017. Available from: https://cdr.lib.unc.edu/record/uuid:daa2bfd7-dbd7-45bc-a81f-03e520f2abea

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of North Carolina

6. Hehl, Brent. Identifying Genetic Factors Affecting Anthracycline-Induced Cytotoxcity.

Degree: Pharmacology, 2012, University of North Carolina

 The molecular mechanisms responsible for anthracycline-induced cytotoxicity have been elusive despite intensive research over the past half century. Here, hits from a genome-wide association (GWA)… (more)

Subjects/Keywords: School of Medicine; Department of Pharmacology

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Hehl, B. (2012). Identifying Genetic Factors Affecting Anthracycline-Induced Cytotoxcity. (Thesis). University of North Carolina. Retrieved from https://cdr.lib.unc.edu/record/uuid:47028df8-0e83-4c8c-a186-2a26d471359e

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Hehl, Brent. “Identifying Genetic Factors Affecting Anthracycline-Induced Cytotoxcity.” 2012. Thesis, University of North Carolina. Accessed September 19, 2020. https://cdr.lib.unc.edu/record/uuid:47028df8-0e83-4c8c-a186-2a26d471359e.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Hehl, Brent. “Identifying Genetic Factors Affecting Anthracycline-Induced Cytotoxcity.” 2012. Web. 19 Sep 2020.

Vancouver:

Hehl B. Identifying Genetic Factors Affecting Anthracycline-Induced Cytotoxcity. [Internet] [Thesis]. University of North Carolina; 2012. [cited 2020 Sep 19]. Available from: https://cdr.lib.unc.edu/record/uuid:47028df8-0e83-4c8c-a186-2a26d471359e.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Hehl B. Identifying Genetic Factors Affecting Anthracycline-Induced Cytotoxcity. [Thesis]. University of North Carolina; 2012. Available from: https://cdr.lib.unc.edu/record/uuid:47028df8-0e83-4c8c-a186-2a26d471359e

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of North Carolina

7. Song, Gina. Immune Mechanisms Regulating Pharmacokinetics and Pharmacodynamics of PEGylated Liposomal Anticancer Agents.

Degree: 2014, University of North Carolina

 Nanotechnology has made significant advances in drug delivery system for the treatment of cancer. Among various nanoparticle (NP) platforms, liposomes have been most widely used… (more)

Subjects/Keywords: Pharmaceutical chemistry; Nanotechnology; Pharmacology; Eshelman School of Pharmacy; Division of Pharmacotherapy and Experimental Therapeutics

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Song, G. (2014). Immune Mechanisms Regulating Pharmacokinetics and Pharmacodynamics of PEGylated Liposomal Anticancer Agents. (Thesis). University of North Carolina. Retrieved from https://cdr.lib.unc.edu/record/uuid:0cd2d931-7196-467e-89c2-ab3fc0bf5a31

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Song, Gina. “Immune Mechanisms Regulating Pharmacokinetics and Pharmacodynamics of PEGylated Liposomal Anticancer Agents.” 2014. Thesis, University of North Carolina. Accessed September 19, 2020. https://cdr.lib.unc.edu/record/uuid:0cd2d931-7196-467e-89c2-ab3fc0bf5a31.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Song, Gina. “Immune Mechanisms Regulating Pharmacokinetics and Pharmacodynamics of PEGylated Liposomal Anticancer Agents.” 2014. Web. 19 Sep 2020.

Vancouver:

Song G. Immune Mechanisms Regulating Pharmacokinetics and Pharmacodynamics of PEGylated Liposomal Anticancer Agents. [Internet] [Thesis]. University of North Carolina; 2014. [cited 2020 Sep 19]. Available from: https://cdr.lib.unc.edu/record/uuid:0cd2d931-7196-467e-89c2-ab3fc0bf5a31.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Song G. Immune Mechanisms Regulating Pharmacokinetics and Pharmacodynamics of PEGylated Liposomal Anticancer Agents. [Thesis]. University of North Carolina; 2014. Available from: https://cdr.lib.unc.edu/record/uuid:0cd2d931-7196-467e-89c2-ab3fc0bf5a31

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of North Carolina

8. Roberts, Patrick. Targeting Ras and Rho Family GTPases for the Treatment of Cancer Through Inhibition of CAAX-Signaled Modifications and the ERK MAPK Pathway.

Degree: 2008, University of North Carolina

 Ras and Rho family GTPases share many structural and biochemical similarities while regulating distinct cellular functions. One such similarity is the carboxyl-terminal CAAX motif (C… (more)

Subjects/Keywords: Eshelman School of Pharmacy; Division of Pharmacotherapy and Experimental Therapeutics

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Roberts, P. (2008). Targeting Ras and Rho Family GTPases for the Treatment of Cancer Through Inhibition of CAAX-Signaled Modifications and the ERK MAPK Pathway. (Thesis). University of North Carolina. Retrieved from https://cdr.lib.unc.edu/record/uuid:3f483630-1fb8-4ca3-97e6-5a9984477b03

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Roberts, Patrick. “Targeting Ras and Rho Family GTPases for the Treatment of Cancer Through Inhibition of CAAX-Signaled Modifications and the ERK MAPK Pathway.” 2008. Thesis, University of North Carolina. Accessed September 19, 2020. https://cdr.lib.unc.edu/record/uuid:3f483630-1fb8-4ca3-97e6-5a9984477b03.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Roberts, Patrick. “Targeting Ras and Rho Family GTPases for the Treatment of Cancer Through Inhibition of CAAX-Signaled Modifications and the ERK MAPK Pathway.” 2008. Web. 19 Sep 2020.

Vancouver:

Roberts P. Targeting Ras and Rho Family GTPases for the Treatment of Cancer Through Inhibition of CAAX-Signaled Modifications and the ERK MAPK Pathway. [Internet] [Thesis]. University of North Carolina; 2008. [cited 2020 Sep 19]. Available from: https://cdr.lib.unc.edu/record/uuid:3f483630-1fb8-4ca3-97e6-5a9984477b03.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Roberts P. Targeting Ras and Rho Family GTPases for the Treatment of Cancer Through Inhibition of CAAX-Signaled Modifications and the ERK MAPK Pathway. [Thesis]. University of North Carolina; 2008. Available from: https://cdr.lib.unc.edu/record/uuid:3f483630-1fb8-4ca3-97e6-5a9984477b03

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

.